Patent: 9,895,380
✉ Email this page to a colleague
Summary for Patent: 9,895,380
Title: | Methods and pharmaceutical compositions for the treatment of hepatitis B virus infection |
Abstract: | The present invention relates to methods and pharmaceutical compositions for the treatment of hepatitis B virus infection. In particular, the present invention relates to farnesoid X receptor (FXR) agonists for use in a method for the treatment of hepatitis B virus infection in a subject in need thereof. |
Inventor(s): | Andre; Patrice (Lyons, FR), Lotteau; Vincent (Lyons, FR), Radreau; Pauline (Lyons, FR), Gilardone; Marine (Millery, FR), Patin; Amaury (Lausanne, CH), Roche; Didier (Ecully, FR), Cravo; Daniel (Montesson, FR), Hallakou-Bozec; Sophie (Antony, FR) |
Assignee: | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris, FR) UNIVERSITE CLAUDE BERNARD--LYON 1 (Villeurbanne, FR) ENS--ECOLE NORMALE SUPERIEURE DE LYON (Lyons, FR) CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (Paris, FR) EDELRIS (Lyons, FR) POXEL (Lyons, FR) |
Application Number: | 14/917,958 |
Patent Claims: | see list of patent claims |
Details for Patent 9,895,380
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Zr Pharma& Gmbh | PEGASYS | peginterferon alfa-2a | Injection | 103964 | 10/16/2002 | ⤷ Try a Trial | 2033-09-11 |
Zr Pharma& Gmbh | PEGASYS | peginterferon alfa-2a | Injection | 103964 | 01/07/2004 | ⤷ Try a Trial | 2033-09-11 |
Zr Pharma& Gmbh | PEGASYS | peginterferon alfa-2a | Injection | 103964 | 09/29/2011 | ⤷ Try a Trial | 2033-09-11 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |